(2015) Hypolipidemic effects of Solidagochilensis hydroalcoholic extract and its major isolated constituent quercetrin in cholesterol-fed rats, Pharmaceutical Biology, 53:10, 1488-1495, DOI: 10.3109/13880209.2014 Objective: This study evaluates the hypolipidemic and antioxidant effects of hydroalcoholic extract (HE) and quercetrin from S. chilensis aerial parts in cholesterol-fed rats. Materials and methods: The HE was analyzed by high-performance liquid chromatography, followed by quercetrin isolation. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 d) were treated with HE (150, 300, and 600 mg/kg p.o.; n ¼ 6), simvastatin (4 mg/kg p.o.; n ¼ 6), or quercetrin (10 mg/kg p.o.; n ¼ 6) once a day for 30 d. During this period, a highcholesterol diet was maintained until the 30th day of treatment.Results: Rats treated with HE (150, 300, and 600 mg/kg) and quercetrin showed decreased serum levels of total cholesterol (À19.9, À27.5, À31.0, and À39.4%), lipoprotein-cholesterol (À36.0, À37.5, À43.3, and À59.4%), and triacylglycerides (À15.6, À23.5, À29.8, and À27.2%) when compared with the control group similar to simvastatin. Moreover, treatment with HE and quercetrin decreased hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity (35.1% on average) and increased fecal cholesterol levels (38.2% on average). Discussion and conclusions: Our results suggest that hypolipidemic effects of HE are associated with it modulating the activity of HMG-CoA reductase and its interference in the reabsorption and/or excretion of intestinal lipids. Solidago chilensis and its main constituent, quercetrin, may thus be effective as cholesterol-lowering agents and in preventing atherosclerosis.